Global Scabies Treatment Market: valued at US$ XX Mn in 201X and expected to grow at X% Compound Annual Growth Rate (CAGR) over 201X to 202X
Scabies is an infectious skin disease caused by microscopic mites known as Sarcoptes scabiei, that lives inside human skin. The mite’s burrows into the skin and lay eggs after staying for two to three weeks. Scabies is an itchy, rash and pimple like skin disease condition found, globally. Scabies is a highly contagious disease and can pass through simple contact with affected person. The disease is pruritic in nature. The common sites for the rash are wrist elbow, armpit, waist, area between the fingers. Combination medicines are prescribed by physician are permethrin cream, benzyl benzoate lotion, crotamiton cream, sulfur ointment and one percent lindane lotion. In some critical condition the patient has been prescribed with antihistamines, antibiotics and steroid creams. The more aggressive treatment in worst cases anthelmintic is given orally.
Scabies Treatment Market Outline: Improper hygienic conditions and environmental factors are the key factor to increase the number of people affected to scabies. Moreover, low cost of drugs, increase in R&D for the innovation of newer drugs, rapid escalation of global population with poor hygienic, and increase in healthcast expenditure are anticipated to fuel the scabies treatment market. Moreover, homecare remedies for the scabies treatment and limited number of advanced therapeutics are expected to restrain the growth of scabies treatment market.
For request sample: https://precisionbusinessinsights.com/request-sample/?product_id=23822
Scabies Treatment Market: Drivers & Restraints
According to the World Health Organization, there are 300 million cases of scabies globally every year. The market is driven in Pacific and Latin America due to high prevalence. Scabies market is expected to rise in countries having majority of young population like all the developing countries. The environmental factors are responsible for the scabies and will be driving the scabies treatment market during the forecast period. The homecare remedies can be a restraint as they will hinder the market of medications available on prescriptions.
North America accounts for high market share in scabies treatment market
Geographically, scabies treatment market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific except Japan, Japan, and Middle East & Africa. North America accounts for high market share in scabies treatment market as approximately one million of affected including all age groups and sex and socio-economic status followed by Western and Eastern Europe including Middle east and Africa where the prevalence is greater than 10 per cent, although Asia Pacific and Latin America has comparatively more prevalent in children than from adults. Japan having less population with other hygienic facilities, the market here is here is stable. Overall the market share for scabies treatment will be rising as approximately 300 million people are reported with scabies around the world every year.
Precision Business Insights (PBI) in its report titled “Scabies Treatment Market”: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 20XX-20XX and Forecast 20XX-20XX” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast.
Market Scope: Scabies Treatment Market

Scabies treatment market is segmented on the basis of drug type, route of administration, and distribution channel

Based on the drug type, scabies treatment market is segmented into the following:
• Sulphur Ointment
• Benzyl Benzoate Lotion
• Lindane Lotion
• Crotamiton Cream
• Permethrin Cream
• Others

Based on the route of administration, this market is segmented into the following:
• Oral
• Topical

Based on the distribution channel, this market is segmented into the following:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Based on the geography, this market is segmented into the following:

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
• Eastern Europe (Russia)
• Asia Pacific (China, India, ASEAN, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa)

For more information: https://precisionbusinessinsights.com/market-reports/scabies-treatment-market/